A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of ASP3700 in Healthy Subjects

Trial Profile

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of ASP3700 in Healthy Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2014

At a glance

  • Drugs ASP 3700 (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 10 Nov 2014 New trial record
    • 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top